I. Meeting Information
The 20th meeting of the 2nd Board of Directors of Hubei Hendi Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") was convened on June 1, 2026, via telephone and email, with all directors notified. A total of 8 directors were required to attend, and all 8 directors participated. The meeting was chaired by the Company's Chairman, Cheng Zhigang, with senior management present. The convening, holding, and voting procedures of this board meeting complied with the relevant provisions of the Company Law of the People's Republic of China and the Company's Articles of Association, making the meeting legal and effective.